Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?

被引:37
作者
Heikkinen, AM
Niskanen, L
Ryynänen, M
Komulainen, MH
Tuppurainen, MT
Parviainen, M
Saarikoski, S
机构
[1] Kuopio Univ Hosp, Dept Obstet & Gynecol, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland
[3] Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Clin Chem, SF-70210 Kuopio, Finland
关键词
ApoE genotype; postmenopausal hormone replacement therapy LDL cholesterol; prospective study;
D O I
10.1161/01.ATV.19.2.402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postmenopausal hormone replacement therapy (HRT) has favorable effects on the serum lipid profile. and it also decreases the risk of cardiovascular diseases. The apolipoprotein E genotype has influence on serum levels of lipids and lipoproteins; apoE allele epsilon 4 (apoE4) is associated with high total and LDL cholesterol levels. Genotype also influences the lipid responses to treatment with diet and statins, but the effect of HRT in different apoE genotypes is unknown. We studied the effects of HRT on the concentrations of serum lipids in apoE4-positive early postmenopausal women (genotypes 3/4 and 4/4) compared with apoE4-negative women (genotypes 2/3 and 3/3) in a population-based, prospective 5-year study. In all, 232 early postmenopausal women were randomized into 2 treatment soups: an HRT group (n = 116), which received a sequential combination of 2 mg estradiol valerate (E(2)Val) from day 1 to 21 and I mg cyproterone acetate (CPA) from day 12 to 21 (Climen), and a placebo group (n = 116), which received 500 mg/d calcium lactate. Serum concentrations of total, LDL, and HDL cholesterol and triglycerides were measured at baseline and after 2 and 5 years of treatment, A total of 154 women completed the final analysis. During the follow-up period, serum total cholesterol and LDL cholesterol concentrations decreased in the HRT group in apoE4-negative women (8.1% and 17.1%, respectively; P < 0.001) but did not change in the HRT group in apoE4-positive women or in the placebo group. Serum HDL cholesterol concentrations decreased in the placebo group (apoE4-negative, 3.9%, P = 0.015; apoE4-positive, 8.1%, P = 0.004) but did not change significantly in the HRT group. Serum triglyceride levels tended to increase in both study groups and genotypes (15.1% to 36.2%, P < 0.038 to 0.001), but no differences were observed between the study groups or genotypes, respectively. Our finding was that in postmenopausal Finnish women LDL cholesterol levels in apoE4-negative subjects respond more favorably to HRT than those in apoE4-positive subjects, This finding has potential importance in postmenopausal women with hypercholesterolemia, if confirmed in other studies.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 32 条
  • [1] ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN
    BARRETTCONNOR, E
    BUSH, TL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14): : 1861 - 1867
  • [2] THE RESPONSE TO LOVASTATIN TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IS MODULATED BY APOLIPOPROTEIN-E POLYMORPHISM
    CARMENA, R
    ROEDERER, G
    MAILLOUX, H
    LUSSIERCACAN, S
    DAVIGNON, J
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07): : 895 - 901
  • [3] DALLONGEVILLE J, 1992, J LIPID RES, V33, P447
  • [4] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21
  • [5] EGGERTSEN G, 1993, CLIN CHEM, V39, P2125
  • [6] EHNHOLM C, 1986, J LIPID RES, V27, P227
  • [7] LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN POSTMENOPAUSAL WOMEN ON CONTINUOUS ESTROGEN PROGESTOGEN THERAPY
    FARISH, E
    FLETCHER, CD
    DAGEN, MM
    HART, DM
    ALAZZAWI, F
    PARKIN, DE
    HOWIE, CA
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (03): : 358 - 364
  • [8] FERRIERES J, 1994, ARTERIOSCLER THROMB, V14, P1554
  • [9] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [10] HALLMAN DM, 1991, AM J HUM GENET, V49, P338